HSBC Analysts Give Sartorius (SRT3) a €86.00 Price Target
A number of other research firms have also recently weighed in on SRT3. Deutsche Bank set a €90.00 ($111.11) price target on Sartorius and gave the stock a neutral rating in a report on Thursday, February 1st. Nord/LB set a €75.00 ($92.59) price target on Sartorius and gave the stock a sell rating in a report on Friday, February 2nd. Warburg Research set a €90.00 ($111.11) price target on Sartorius and gave the stock a buy rating in a report on Wednesday, January 31st. Kepler Capital Markets set a €78.00 ($96.30) target price on Sartorius and gave the company a neutral rating in a research report on Wednesday, January 31st. Finally, Berenberg Bank set a €85.00 ($104.94) target price on Sartorius and gave the company a buy rating in a research report on Wednesday, January 31st. Three equities research analysts have rated the stock with a sell rating, six have issued a hold rating and two have given a buy rating to the stock. Sartorius has a consensus rating of Hold and a consensus price target of €79.55 ($98.20).
Sartorius (FRA:SRT3) opened at €97.65 ($120.56) on Wednesday. The firm has a market capitalization of $7,060.00 and a P/E ratio of 79.39. Sartorius has a fifty-two week low of €64.20 ($79.26) and a fifty-two week high of €100.00 ($123.46).
Sartorius Aktiengesellschaft provides laboratory and process technologies and equipment worldwide. The company operates through two divisions, Bioprocess Solutions, and Lab Products & Services. The Bioprocess Solutions division offers products, technologies, and services ranging from fermentation, cell cultivation, filtration, and purification to media storage and transportation for the biopharmaceutical industry.
Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.